The IPO market may be all but closed, except for a few biopharmaceutical companies. And many start-ups are seeking relief from the government’s bailout funds.
But mostly, venture capital investing has not yet shown signs of devastation from the Covid-19.
According to the PitchBook-NVCA Venture Monitor report, there were 2,298 venture capital deals totaling $34.2
